Carotid Intima-Media Thickness (CIMT) - not your ordinary carotid artery sonogram test!

WHAT IS CIMT (Carotid Artery Intima-Media Thickness)?

CIMT is a new non-invasive ultrasound test that is being recommended by the American Heart Association and the American College of Cardiology to screen for heart disease in apparently healthy individuals ages 45 or greater.  CIMT stands for Carotid Intima-Media Thickness.

Staying abreast of the latest medical techniques and protocols, the doctors of Integrated Medicine of Mount Kisco's, Dr. Wald and Dr. Shah now offers our new CardioHealth ® testing as part of their biomarker and cardiovascular health program. 


This is a noninvasive test which is performed with a high-resolution B-mode ultrasound transducer. The test is safe, painless and takes about twenty minutes. After applying conducting jelly to the skin over your neck, a small hand-held transducer is applied to image the carotid arteries. The sonographer measures the combined thicknesses of the intimal and medial layers of the carotid artery walls.


The carotid arteries provide a “window” to the coronary arteries. Not only do they have similar risk factors – more importantly, the relationship between the atherosclerotic burden in a carotid artery and a coronary artery is the same as between any two coronary arteries. Thus carotic aterosclerosis provides a window to the degree of coronary atherosclerosis in an individual. CIMT is an independent predictor of future cardiovascular events, including heart attacks, cardiac death, and stroke.


CIMT is a value which tends to increase with age. Published studies of CIMT measurements in 15,000 patients ages 45 to 65 have made it possible to develop a reference range of what is “normal” at different ages. After your measurements are taken, the results are compared to this same computerized database of 15,000 patients.

A report is generated which tells us your vascular age. If your vascular matches your chronological age or younger, then you have a lower risk for heart disease. If your vascular age exceeds your chronological age, then it alerts us to be more aggressive at controlling those risk factors associated with heart disease. Importantly, with various therapies, it is possible to achieve regression or slow down progression of the CIMT. A follow-up CIMT is done six months to a year after therapy is initiated to evaluate the effectiveness of those therapies.


As an "integrated" health care office we cross-compare various tests such as the CIMT to other cardiovascular and non-cardiovascular tests to potentially yield greater understanding of your health issues. For example, the CIMT test is a test of harness, thickening and/or plaque within arteries; these findings can be related to loss of bone density (osteoporosis) because calcium leaching from bones may harden arteries. Breast cancer incidence is higher among women with both hardening of the arteries/plaque with loss of bone density. Low vitamin D3 levels (below 75 ug/nL) may increase the risk of all of these issues namely, arteriosclerosis (hardening of the arteries), loss of bone density and/or breast cancer...also arthritis!  As you can see, our "integrated" or holistic perspective can recognize these issues and risk factors so that we can develop personalized health plans for our patients. A patient would have to visit several doctors to diagnose and treat plaque within arteries, osteoporosis, breast cancer, low vitamin D3 and arthritis. Our treatment plans encompass all of these in one place. We commonly refer, and are happy to communicate with, your other doctors.